Noul Co. Ltd.
Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was… Read more
Noul Co. Ltd. (376930) - Total Liabilities
Latest total liabilities as of June 2025: ₩18.53 Billion KRW
Based on the latest financial reports, Noul Co. Ltd. (376930) has total liabilities worth ₩18.53 Billion KRW as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Noul Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Noul Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Noul Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Noul Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Susquehanna Community Financial Inc
PINK:SQCF
|
USA | $563.33 Million |
|
Conrad Asia Energy Ltd
AU:CRD
|
Australia | AU$1.23 Million |
|
Electrotherm (India) Limited
NSE:ELECTHERM
|
India | ₹21.28 Billion |
|
American Eagle Gold Corp
PINK:AMEGF
|
USA | $2.28 Million |
|
De Poan Pneumatic
TWO:1570
|
Taiwan | NT$105.16 Million |
|
Biotalys NV
BR:BTLS
|
Belgium | €9.18 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Noul Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.75 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Noul Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Noul Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of Noul Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩17.64 Billion | +40.14% |
| 2023-12-31 | ₩12.59 Billion | -12.92% |
| 2022-12-31 | ₩14.46 Billion | -20.15% |
| 2021-12-31 | ₩18.10 Billion | -35.81% |
| 2020-12-31 | ₩28.21 Billion | +282.84% |
| 2019-12-31 | ₩7.37 Billion | -- |